Intravitreal triamcinolone, bevacizumab and pegaptanib for occult choroidal neovascularization-Reference-Cited by-同舟云学术

Intravitreal triamcinolone, bevacizumab and pegaptanib for occult choroidal neovascularization

Published:2010-10-14 Issue:8 Volume:88 Page:e305-e310
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:

Author:

Forte Raimondo,Cennamo Gilda,Finelli Marialuisa,Cesarano Ida,D’Amico Giuseppe,De Crecchio Giuseppe,Cennamo Giovanni

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-3768.2010.02021.x/fullpdf

Reference43 articles.

1. Evolving guidelines for intravitreous injections;Aiello;Retina,2004

2. Statistical attributes of the steroid hypertensive response in the clinically normal eye, I: the demonstration of three levels of response;Armaly;Invest Ophthalmol,1965

3. Pegaptanib sodium for occult choroidal neovascularization in neovascular age-related macular degeneration: a prospective case series;Atmani;Eye,2009

4. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration;Augustin;Ophthalmology,2006

5. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration;Avery;Ophthalmology,2006

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VR-10 polypeptide interacts with CD36 to induce cell apoptosis and autophagy in choroid-retinal endothelial cells: Identification of VR-10 as putative novel therapeutic agent for choroid neovascularization (CNV) treatment;Peptides;2022-11

2. Cyclic RGD Peptide Targeting Coated Nano Drug Co-Delivery System for Therapeutic Use in Age-Related Macular Degeneration Disease;Molecules;2020-10-23

3. Low luminance visual acuity in patients with central serous chorioretinopathy;Clinical and Experimental Optometry;2013-01-01

4. KH902 suppresses high glucose-induced migration and sprouting of human retinal endothelial cells by blocking VEGF and PIGF;Diabetes, Obesity and Metabolism;2012-09-30

5. Low-fluence photodynamic therapy combinations in the treatment of exudative age -related macular degeneration;INT J OPHTHALMOL-CHI;2012